Stellar Biotechnologies' Grant

Stellar Biotechnologies raised a round of funding on March 06, 2009. Investors include National Science Foundation.

Stellar Biotechnologies (NASDAQ: SBOT) specializes in Keyhole Limpet Hemocyanin (KLH) protein and is focused in the rapidly-evolving field of immunotherapy. KLH is an important immune-stimulating mole…

Articles about Stellar Biotechnologies' Grant: